Research and Markets: Future Horizons and Growth Strategies in the Prostatic Acid Phosphatase Testing Market 2015-2019 - Reviews Features and Operating Characteristics of Automated Analyzers

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/cnb4kf/20152019_future) has announced the addition of the "2015-2019 Future Horizons and Growth Strategies in the Prostatic Acid Phosphatase Testing Market: Supplier Shares and Country Forecasts" report to their offering.

The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease. During the next five years, the worldwide cancer testing market is promising to be an exciting, dynamic and rapidly expanding field.

Anticipated technological breakthroughs will create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The rise in the geriatric population will further compound the growing demand for malignancy assays and the rapid market expansion worldwide.

This report presents a detailed analysis of the PAP testing market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan, including clinical significance and current laboratory practice; 5-year test volume and sales forecasts by country and market segment; as well as sales and market shares for major suppliers.

The report also examines market applications of DNA probes, biochips/microarrays, monoclonal antibodies, immunoassays, IT, chromosome analysis, and other technologies; reviews features and operating characteristics of automated analyzers; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies alternative market penetration strategies and entry barriers/risks.

Companies Mentioned

  1. Abbott
  2. AdnaGen/Alere
  3. Agilent Technologies
  4. Applied Gene Technologies
  5. Arca Biopharma
  6. Beckman Coulter/Danaher
  7. Becton Dickinson
  8. Biomedical Diagnostics
  9. bioMerieux
  10. Bio-Rad
  11. CellSearch
  12. Cepheid
  13. Correlogic Systems/Vermillion
  14. Decode Genetics
  15. Diadexus
  16. Diagnocure
  17. Diasorin
  18. Eiken Chemical
  19. Elitech Group
  20. Epigenomics
  21. Enterix
  22. Enzo Biochem
  23. Exact Sciences
  24. Fujirebio
  25. Guided Therapeutics
  26. Hologic/Gen-Probe
  27. Kreatech/Leica
  28. Kyowa Medex
  29. Mackay Life Sciences
  30. Myriad Genetics
  31. OncoLab
  32. Ortho-Clinical Diagnostics
  33. Panacea Pharmaceuticals
  34. Polartechnics

For more information visit http://www.researchandmarkets.com/research/cnb4kf/20152019_future.

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For EST Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Enzymes

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For EST Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Enzymes